Investigations of lichen secondary metabolites with potential anticancer activity

Lichen Secondary Metabolites: Bioactive Properties and Pharmaceutical Potential

Volumn , Issue , 2015, Pages 127-146

  Stanojković, Tatjana ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944526968     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-13374-4_5     Document Type: Chapter

References (94)

1. Babula P, Adam V, Havel L et al (2009) Noteworthy secondary metabolites naphthoquinones- their occurrence, pharmacological properties and analysis. Curr Pharm Anal 5:47-68
2. Bačkorová M, Bačkor M, Mikeš J et al (2011) Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid. Toxicol In Vitro 25:37-44
3. Bačkorová M, Jendželovský R, Kello M et al (2012) Lichen secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 human cancer cell lines. Toxicol In Vitro 26: 462-468
4. Bazin MA, Le Lamer AC, Delcros JG et al (2008) Synthesis and cytotoxic activities of usnic acid derivatives. Bioorg Med Chem 16:6860-6866
5. Behera BC, Adawadkar B, Makhija U (2003) Inhibitory activity of xanthine oxidase and superoxide-scavenging activity in some taxa of the lichen family Graphidaceae. Phyto-medicine 10:536-543
6. Behera BC, Adawadkar B, Makhija U (2004) Capacity of some Graphidaceous lichens to scavenge superoxide and inhibition of tyrosinase and xanthine oxidase activities. Curr Sci 87:83-87
7. Bézivin C, Tomasi S, Rouaud I et al (2004) Cytotoxic activity of compounds from the lichen: Cladonia convoluta. Planta Med 70:874-877
8. Bogo D, Matos MFC, Honda NK et al (2010) In vitro antitumor activity of orsellinates. Z Naturforsch 65:43-48
9. Boustie J, Grube M (2005) Lichens-a promising source of bioactive secondary metabolites. Plant Genet Resour 3:273-287
10. Brandão LF, Alcantara GB, Matos Mde F et al (2013) Cytotoxic evaluation of phenolic compounds from lichens against melanoma cells. Chem Pharm Bull (Tokyo) 61:176-183
11. Brisdelli F, Perilli M, Sellitri D et al (2013) Cytotoxic activity and antioxidant capacity of purified lichen metabolites: An in vitro study. Phytother Res 27:431-437
12. Brunauer G, Hager A, Krautgartner WD et al (2006) Experimental studies on Lecanora rupicola (L.) Zahlbr.: Chemical and microscopical investigations of the mycobiont and re-synthesis stages. Lichenologist 38:577-585
13. Brunauer G, Hager A, Grube M et al (2007) Alterations in secondary metabolism of aposymbiotically grown mycobionts of Xanthoria elegans and cultured resynthesis stages. Plant Physiol Biochem 45:146-151
14. Burlando B, Ranzato E, Volante A et al (2009) Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds. Planta Med 75: 607-613
15. Burton JF, Cain BF (1959) Antileukæmic activity of polyporic acid. Nature 184:1326-1327
16. Cain BF (1966) Potential anti-tumour agents. IV. Polyporic acid series. J Chem Soc Perkin 11:1041-1045
17. Cardarelli M, Serino G, Campanella L et al (1997) Antimitotic effects of usnic acid on different biological systems. Cell Mol Life Sci 53:667-672
18. Cheng B, Cao S, Vasquez V et al (2013) Identification of anziaic acid, a lichen depside from Hypotrachyna sp., as a new topoisomerase poison inhibitor. PLoS One 8(4):e60770
19. Cohen PA, Towers GHN (1995) Anthraquinones and phenanthroperylenequinones from Nephroma laevigatum. J Nat Prod 58:520-526
20. Correché ER, Carrasco M, Giannini F et al (2002) Cytotoxic screening activity of secondary lichen metabolites. Acta Farm Bonaerense 21:273-278
21. Correché ER, Enriz RD, Piovano M et al (2004) Cytotoxic and apoptotic effects on hepatocytes of secondary metabolites obtained from lichens. Altern Lab Anim 32:605-615
22. Crittenden D, Porter N (1991) Lichen-forming fungi: Potential sources of novel metabolites. Trends Biotechnol 9:409-414
23. Demleitner S, Kraus J, Franz G (1992) Synthesis and antitumour activity of derivatives of curdlan and lichenan branched at C-6. Carbohydr Res 226:239-246
24. Einarsdóttir E, Groeneweg J, Björnsdóttir GG et al (2010) Cellular mechanisms of the anticancer effects of the lichen compound usnic acid. Planta Med 76:969-974
25. Elix JA (1996) Biochemistry and secondary metabolites. In: Nash TH III (ed) Lichen biology, 1st edn. Cambridge University Press, Cambridge, pp 155-180
26. Elix JA, Stocker-Wörgötter E (2008) Biochemistry and secondary metabolites. In: Nash TH III (ed) Lichen biology, 2nd edn. Cambridge University Press, Cambridge, pp 104-133
27. Ernst-Russell MA, Chai CLL, Hurne AM et al (1999) Revision and cytotoxic activity of the scabrosin esters, epidithiopiperazinediones from the Lichen Xanthoparmelia scabrosa. Aust J Chem 52:279-283
28. Fahselt D (1994) Secondary biochemistry of lichens. Symbiosis 16:117-165
29. Fakim AG (2006) Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med 27:1-93
30. Fujikawa F, Hirai K, Hirayama T et al (1972) Influence of cytochalasin B on hyphal morpho-genesis of Aspergillus nidulans. Yakugaku Zasshi 92:823-827
31. Fukuoka F, Nakanishi M, Shibata S et al (1968) Polysaccharides in lichens and fungi. II. Antitumor activities on sarcoma-180 of the polysaccharide preparations from Gyrophora esculenta Miyoshi, Cetraria islandica (L.) Ach. var. orientalis Asahina, and some other lichens. Gann 59:421-432
32. Guo J, Li ZL, Wang AL et al (2011) Three new phenolic compounds from the lichen Thamnolia vermicularis and their antiproliferative effects in prostate cancer cells. Planta Med 77: 2042-2046
33. Hager A, Brunauer G, Türk R et al (2008) Production and bioactivity of common lichen meta-bolites as exemplified by Heterodea muelleri (Hampe) Nyl. J Chem Ecol 34:113-120
34. Han D, Matsumaru K, Rettori D et al (2004) Usnic acid-induced necrosis of cultured mouse hepatocytes: Inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol 67:439-451
35. Haraldsdóttir S, Gulaugsdóttir E, Ingólfsdóttir K et al (2004) Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro. Planta Med 70:1098-1100
36. Hirayama T, Fujikawa F, Yosioka I et al (1974) A new depsidone oxyphysodic acid isolated from a lichen Parmelia enteromorphia Ach. Chem Pharm Bull (Tokyo) 22:1678-1680
37. Hirayama T, Fujikawa F, Kasahara T et al (1980) Anti-tumor activities of some lichen products and their degradation products. Yakugaku Zasshi 100:755-759
38. Huneck S (1999) The significance of lichens and their metabolites. Naturwissenschaften 86: 559-570
39. Huneck S, Himmelreich U (1995) Arthogalin, a cyclic depsipeptide from the lichen Arthothelium galapagoense. Z Naturforsch 50:1101-1103
40. Ingólfsdóttir K (2002) Usnic acid. Phytochemistry 61:729-736
41. Ivanova V, Backor M, Dahse HM et al (2010) Molecular structural studies of lichen substances with antimicrobial, antiproliferative, and cytotoxic effects from Parmelia subrudecta. Prep Biochem Biotechnol 40:377-388
42. Johnson CJ, Bennett JP, Biro SM et al (2011) Degradation of the disease-associated prion protein by a serine protease from lichens. PLoS One 6:19836-19837
43. Karikas GA (2010) Anticancer and chemopreventing natural products: Some biochemical and therapeutic aspects. J BUON 15:627-638
44. Koparal AT, Tuylu BA, Turk H (2006) In vitro cytotoxic activities of (+)-usnic acid and (-)-usnic acid on V79, A549, and human lymphocyte cells and their nongenotoxicity on human lymphocytes. Nat Prod Res 20:1300-13007
45. Koparal AT, Ulus G, Zeytinoglu M et al (2010) Angiogenesis inhibition by a lichen compound olivetoric acid. Phytother Res 24:754-758
46. Kosanic M, Rankovic B, Stanojkovic T (2012a) Antioxidant, antimicrobial, and anticancer activity of 3 Umbilicaria species. J Food Sci 77:20-25
47. Kosanic MM, Rankovic BR, Stanojkovic TP (2012b) Antioxidant, antimicrobial and anticancer activities of three Parmelia species. J Sci Food Agric 92:1909-1916
48. Kosanic M, Manojlovic N, Jankovic S et al (2013) Evernia prunastri and Pseudoevernia furfuraceae lichens and their major metabolites as antioxidant, antimicrobial and anticancer agents. Food Chem Toxicol 53:112-118
49. Kristmundsdóttir T, Aradottir HA, Ingólfsdóttir K et al (2002) Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture. J Pharm Pharmacol 54:1447-1452
50. Kumar KCS, Muller K (1999) Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth. J Nat Prod 62:821-823
51. Kupchan SM, Kopperman HL (1975) l-usnic acid: Tumor inhibitor isolated from lichens. Experientia 31:625
52. Lahlou M (2013) The success of natural products in drug discovery. Pharmacol Pharm 4:17-31
53. Lawrey JD (1986) Biological role of lichen substances. Bryologist 89:111-122
54. Liu H, Liu Y, Liu Y et al (2010) A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells. Chem Biol Interact 188:598-606
55. Magaya MC, Yeang DP, Ahkeboyee BGW (2013) Arthogalin inhibits the growth of murine malignant prostate sarcoma cells in vitro. J Pharm Pharmacol Res 3:22-26
56. Manojlovic N, Rankovic B, Kosanic M et al (2012) Chemical composition of three Parmelia lichens and antioxidant, antimicrobial and cytotoxic activities of some their major metabolites. Phytomedicine 19:1166-1172
57. Mayer M, O’Neill MA, Murray KE et al (2005) Usnic acid: A non-genotoxic compound with anti-cancer properties. Anticancer Drugs 16:805-809
58. Miao V, Coeffet M, Brown D et al (2001) Genetic approaches to harvesting lichen products. Trends Biotechnol 19:349-355
59. Millot M, Tomasi S, Articus K et al (2007) Metabolites from the lichen Ochrolechia parella growing under two different heliotropic conditions. J Nat Prod 70:316-318
60. Moerman KL, Chai CL, Waring P (2003) Evidence that the lichen-derived scabrosin esters target mitochondrial ATP synthase in P388D1 cells. Toxicol Appl Pharmacol 190:232-240
61. Molnár K, Farkas E (2010) Current results on biological activities of lichen secondary metabolites: A review. Z Naturforsch 65:157-173
62. Muggia L, Schmitt I, Grube M (2009) Lichens as treasure chests of natural products. SIM News 85-97
63. Müller K (2001) Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol 56:9-16
64. Nishikawa Y, Ohno H (1981) Studies on the water-soluble constituents of lichens. IV. Effect of antitumor lichen-glucans and related derivatives on the phagocytic activity of the reticuloendothelial system in mice. Chem Pharm Bull (Tokyo) 29:3407-3410
65. Nishikawa Y, Takeda T, Shibata S et al (1969) Polysaccharides in lichens and fungi. 3. Further investigation on the structures and the antitumor activity of the polysaccharides from Gyrophora esculenta Miyoshi and Lasallia papulosa Llano. Chem Pharm Bull (Tokyo) 17:1910-1916
66. Nishikawa Y, Yoshimoto K, Horiuchi R et al (1979) Studies on the water-soluble constituents of lichens. III. Changes in antitumor effect caused by modifications of pustulan- and lichenan-type glucans. Chem Pharm Bull (Tokyo) 27:2065-2072
67. O’Neill MA, Mayer M, Murray KE et al (2010) Does usnic acid affect microtubules in human cancer cells? Braz J Biol 70:659-664
68. Ogmundsdóttir HM, Zoëga GM, Gissurarson SR, Ingólfsdóttir K (1998) Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes. J Pharm Pharmacol 50:107-115
69. Oksanen I (2006) Ecological and biotechnological aspects of lichens. Appl Microbiol Biotechnol 73:723-734
70. Pejin B, Iodice C, Bogdanović G et al (2013) Stictic acid inhibits cell growth of human colon adenocarcinoma HT-29 cells. Arab J Chem. doihttp://dx.doi.org/10.1016/j.arabjc.2013.03.003:10.1016/j.arabjc.2013.03.003
71. Rankovic BR, Kosanic MM, Stanojkovic TP (2011) Antioxidant, antimicrobial and anticancer activity of the lichens Cladonia furcata, Lecanora atra and Lecanora muralis. BMC Complement Altern Med 11:97
72. Rankovic B, Kosanic M, Stanojkovic T et al (2012) Biological activities of Toninia candida and Usnea barbata together with their norstictic acid and usnic acid constituents. Int J Mol Sci 13: 14707-14722
73. Rankovic B, Kosanic M, Manojlovic N et al (2014) Chemical composition of Hypogymnia physodes lichen and biological activities of some its major metabolites. Med Chem Res 23: 408-416
74. Ren MR, Hur JS, Seo KI et al (2009) Anti-proliferative effects of Lethariella zahlbruckneri extracts in HT-29 human colon cancer cells. Food Chem 47:2157-2162
75. Ribeiro-Costa RM, Alves AJ, Santos NP et al (2004) In vitro and in vivo properties of usnic acid encapsulated into PLGA-microspheres. J Microencapsul 21:371-384
76. Richardson DHS (1991) Lichens as biological indicators-recent developments. In: Jeffrey DW, Madden B (eds) Bioindicators and environmental management. Academic, London, pp 263-272
77. Romagni JG, Dayan FE (2002) Structural diversity of lichen metabolites and their potential use. In: Upadhyay RK (ed) Advances in microbial toxin research and its biotechnological exploitation. Kluwer/Plenum, New York, pp 151-169
78. Russo A, Piovano M, Lombardo L et al (2006) Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells. Anticancer Drugs 17:1163-1169
79. Russo A, Piovano M, Lombardo L et al (2008) Lichen metabolites prevent UV light and nitric oxide-mediated plasmid DNA damage and induce apoptosis in human melanoma cells. Life Sci 83:468-474
80. Russo A, Caggia S, Piovano M et al (2012) Effect of vicanicin and on human prostate cancer cells: Role of Hsp70 protein. Chem Biol Interact 195:1-10
81. Sahu SC, Amankwa-Sakyi M, O’Donnell MW Jr et al (2011) Effects of usnic acid exposure on human hepatoblastoma HepG2 cells in culture. J Appl Toxicol. doihttp://dx.doi.org/10.1002/jat.1721:10.1002/jat.1721
82. Shibamoto T, Wei CI (1984) Mutagenicity of lichen constituents. Environ Mutagen 6:757-762
83. Shibata S, Nishikawa Y, Tanaka M et al (1968) Antitumour activities of lichen polysaccharides. Z Krebsforsch 71:102-104
84. Shrestha G, St. Clair LL (2013) Lichens: A promising source of antibiotic and anticancer drugs. Phytochem Rev 12:229-244
85. Srinivas G, Babykutty S, Sathiadevan PP et al (2007) Molecular mechanism of emodin action: Transition from laxative ingredient to an antitumor agent. Med Res Rev 27:591-608
86. Stocker-Wörgötter E (2008) Metabolic diversity of lichen-forming ascomycetous fungi: Culturing, polyketide and shikimate metabolite production, and PKS genes. Nat Prod Rep 25:188-200
87. Stocker-Wörgötter E, Elix JA (2002) Secondary chemistry of cultured mycobionts: Formation of a complete chemosyndrome by the lichen fungus of Lobaria spathulata. Lichenologist 34: 351-359
88. Takai M, Uehara Y, Beisler JA (1979) Usnic acid derivatives as potential antineoplastic agents. J Med Chem 22:1380-1384
89. Tokiwano T, Satoh H, Obara T et al (2009) A lichen substance as an antiproliferative compound against HL-60 human leukemia cells: 16-O-acetyl-leucotylic acid isolated from Myelochroa aurulenta. Biosci Biotechnol Biochem 73:2525-2527
90. Williams DE, Bombuwala K, Lobkovsky E et al (1998) Ambewelamides A and B, antineoplastic epidithiapiperazinediones isolated from the lichen Usnea sp. Tetrahedron Lett 39:9579-9582
91. Yamamoto Y (2000) Screening of biological activities and isolation of biological active compounds from lichens. Chem Regul Plants 35:169-179
92. Yamamoto Y, Miura Y, Higuchi M et al (1993) Using lichen tissue cultures in modern biology. Bryologist 96:384-393
93. Yamamoto Y, Kinoshita Y, Kurokawa T et al (1995) Cell growth and pigment production in suspension cultures of a mycobiont isolated from the lichen Cladonia cristatella. Can J Bot 73: 590-594
94. Yoshimura I, Kurokawa T, Kinoshita Y et al (1994) Lichen substances in cultured lichens. J Hattori Bot Lab 76:249-261